Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely ...

Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in ...

Chair, President and CEO Susan G. Riel to Retire in 2026Board Conducting Search for New CEOAppoints James A. Soltesz as Chair and Louis P. “Pete” ...